2448. In vitro Activity of Ceftazidime–Avibactam Against Enterobacteriaceae Causing Intra-abdominal, Urinary Tract and Lower Respiratory Tract Infections Collected in Latin America as Part of the INFORM Global Surveillance Program, 2012–2016

BACKGROUND: The dissemination of multi-drug-resistant Enterobacteriaceae (MDR Eba) threatens the treatment of Gram-negative infections. Ceftazidime–avibactam (CAZ-AVI) is a novel antimicrobial with activity against Eba producing Class A, C and some Class D β-lactamases. This study evaluates the in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Estabrook, Mark, Kazmierczak, Krystyna, Stone, Gregory G, Sahm, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255069/
http://dx.doi.org/10.1093/ofid/ofy210.2101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255069/
http://dx.doi.org/10.1093/ofid/ofy210.2101

Ejemplares similares